Universe Pharmaceuticals (UPC) Payables (2020 - 2025)

Universe Pharmaceuticals (UPC) has 6 years of Payables data on file, last reported at $8.8 billion in Q3 2025.

• For the quarter ending Q3 2025, Payables fell 18.12% year-over-year to $8.8 billion; the trailing twelve-month figure through Sep 2025 stood at $8.8 billion (down 18.12% YoY), and the FY2025 full-year result was $8.8 billion, down 18.12% from the prior year.
• Payables fell to $8.8 billion in Q3 2025, from $10.8 billion in the prior quarter.
• In the past five years, Payables ranged from a high of $10.8 billion in Q3 2024 to a low of $7.0 million in Q3 2022.
• A 5-year average of $2.5 billion and a median of $11.1 million in 2023 frame the typical range for Payables.
• Across the five-year window, Payables plunged 100.0% in 2021 and jumped 106889.91% in 2024, its largest moves.
• Tracing UPC's Payables over 5 years: stood at $9.6 million in 2021, then fell by 27.3% to $7.0 million in 2022, then surged by 43.59% to $10.1 million in 2023, then jumped by 106889.91% to $10.8 billion in 2024, then slipped by 18.12% to $8.8 billion in 2025.
• Business Quant data shows UPC's Payables at $8.8 billion in Q3 2025, $10.8 billion in Q3 2024, and $12.2 million in Q1 2024.